Charlton, M. R., O’Leary, J. G., Bzowej, N. H., Muir, A. J., Korenblat, K. M., Fenkel, J. M., … Curry, M. P. (2015). Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study. In HEPATOLOGY (Vol. 62, pp. 1387A-1388A). WILEY-BLACKWELL.

Charlton, Michael R., Jacqueline G. O’Leary, Natalie H. Bzowej, Andrew J. Muir, Kevin M. Korenblat, Jonathan M. Fenkel, K Rajender Reddy, et al. “Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study.” In HEPATOLOGY, 62:1387A-1388A. WILEY-BLACKWELL, 2015.

Charlton MR, O’Leary JG, Bzowej NH, Muir AJ, Korenblat KM, Fenkel JM, et al. Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study. In: HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 1387A-1388A.

Charlton, Michael R., et al. “Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study.” HEPATOLOGY, vol. 62, no. 6, WILEY-BLACKWELL, 2015, pp. 1387A-1388A.

Charlton MR, O’Leary JG, Bzowej NH, Muir AJ, Korenblat KM, Fenkel JM, Reddy KR, Lawitz E, Schiano TD, Teperman LW, Fontana RJ, Schiff ER, Fried MW, Doehle B, An D, McNally J, Osinusi A, Brainard DM, McHutchison JG, Brown RS, Curry MP. Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study. HEPATOLOGY. WILEY-BLACKWELL; 2015. p. 1387A-1388A.